Verisk Hi Res Logo.png
Verisk Reports First-Quarter 2024 Financial Results
May 01, 2024 07:15 ET | Verisk Analytics, Inc.
• Consolidated revenues were $704 million, up 8.0%, and up 6.9% on an organic constant currency (OCC) basis for the first quarter of 2024. • Income from continuing operations was $219 million,...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology to Participate in Upcoming Investor Conferences in May
May 01, 2024 07:02 ET | Olema Oncology
SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
bitfarms.jpg
Bitfarms Provides April 2024 Production and Operations Update
May 01, 2024 07:00 ET | Bitfarms Ltd.
- Earns 269 BTC in April 2024 -- Improves corporate energy efficiency 9% to 31 w/TH -- Tracking to 21 EH/s and 21 w/TH in 2024 with transformative fleet upgrade -- Expects VAT refund from Canada of US...
bry-logomark-fullname-rgb-black.jpg
Berry Corporation Reports First Quarter 2024 Financial and Operating Results, Declares Dividend    
May 01, 2024 07:00 ET | Berry Corporation (Bry)
DALLAS, May 01, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced first quarter 2024 results and declared a fixed dividend. The details for today’s...
Beyond-Air-The-Magic-of-Breathing.png
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
May 01, 2024 07:00 ET | Beyond Air™
HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for...
chimerix_logo.jpg
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
May 01, 2024 07:00 ET | Chimerix, Inc.
– Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026 – – No Dose Limiting Toxicity in ONC206 Phase 1...
EWC_Logo_CMYK_Red.jpg
European Wax Center, Inc. to Report First Quarter Fiscal Year 2024 Financial Results on May 15th
May 01, 2024 07:00 ET | European Wax Center, Inc.
PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States,...
barinthuslogo.jpg
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
May 01, 2024 07:00 ET | Barinthus Biotherapeutics
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer.
chefswarehouse.jpg
The Chefs’ Warehouse Reports First Quarter 2024 Financial Results
May 01, 2024 07:00 ET | The Chefs' Warehouse, Inc.
RIDGEFIELD, Conn., May 01, 2024 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the...
Astec Logo Horiz.jpg
Astec Reports First Quarter 2024 Results
May 01, 2024 07:00 ET | Astec Industries, Inc.
First Quarter 2024 Overview (all comparisons are made to the corresponding prior year first quarter unless otherwise specified): Implied orders increased 2.4% sequentially from the fourth...